Search - tctmd.com

Displaying 161 - 180 of 183

Sort: Relevancy | Date

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Todd Neale

February 04, 2020

News Daily News

Combo of Proximal Protection, Double-Layer Stent May Enhance Carotid Stenting

Todd Neale

February 03, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

Fluoroless Cath Promises Less Radiation, but the Tech Is Still Early

Caitlin E. Cox

January 22, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Daily News

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Yael L. Maxwell

January 13, 2020

News Daily News

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Caitlin E. Cox

January 09, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Presentation Controversies and Advances 2019

AngiopoetinLike-3 ( ANGPTL-3) : A Novel Target for Dyslipidemia

Presenter: P.K.Shah

November 15, 2019

Video

» Interview

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

October 18, 2020

Video

» Interview

ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions

October 18, 2020

BIO

Advertisement

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Combo of Proximal Protection, Double-Layer Stent May Enhance Carotid Stenting

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Venous Stents: Long-term Follow-up Plus a New Contender

Fluoroless Cath Promises Less Radiation, but the Tech Is Still Early

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

AngiopoetinLike-3 ( ANGPTL-3) : A Novel Target for Dyslipidemia

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions

Jay Mohan, DO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content